Deaths Prompt Genentech To Pull Psoriasis Drug
Genentech Inc. is withdrawing its psoriasis drug Raptiva from the U.S. market following reports that three patients using the drug died of progressive multifocal leukoencephalopathy, a rare central nervous system infection....To view the full article, register now.
Already a subscriber? Click here to view full article